Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
ClinicalTrials.gov · NCT02320045 · Registry updated: 2016-06-03
- Condition / research focus
- Renal Insufficiency
- Sponsor
- Intarcia Therapeutics
- Countries with listed sites
- Germany · United States
- Registry dates and results
- Start: 2014-11. Completion: 2015-07 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- ITCA 650 (Exenatide in osmotic mini pump) (drug)
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Intarcia Therapeutics Inc.
Boston, Massachusetts, United States
Site recruitment: Not reported - Kiel, Germany